Politico September 18, 2024
By Ben Leonard and Chelsea Cirruzzo

With Lauren Gardner and Daniel Payne

Driving the Day

READING THE PHARMA TEA LEAVES — Democratic presidential candidate Kamala Harris is launching several health care events with providers, advocates and lawmakers in swing states this week, signaling the issue will continue to be a major part of her campaign.

As California attorney general, Harris focused on health care — including challenging drug patent holders and unfair practices in marketing treatments for off-label use.

She’s now leaning into speeding up government drug pricing negotiations to reduce costs to Medicare beneficiaries and has previously supported “march-in” rights, when the government can lower prices by awarding a patent for research it funded to another company. Such measures signal an aggressive stance on drug...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Congress / White House, Govt Agencies, Pharma, Pharma / Biotech
Seniors deserve timely access to care, not bureaucratic hurdles | Viewpoint
Trump names nominees to lead CDC, FDA, and his pick for surgeon general
Trump Nominates Physicians for CDC Director, Surgeon General
Rand roadblock: Biotech bill’s uncertain future
Advocate Health takes to Capitol Hill on hospital at home: 5 notes

Share This Article